Results 21 to 30 of about 2,327,584 (298)
Brain malignancies: Glioblastoma and brain metastases
Brain, the major organ of the central nervous system controls and processes most of body activities. Therefore, the most aggressive brain tumor - glioblastoma and metastases from other organs to the brain are lethal leaving the patients with very short time of survival.
Lah Turnšek, Tamara +2 more
openaire +3 more sources
The role of brachytherapy in the management of brain metastases: a systematic review
© 2020 Termedia Publishing House Ltd.. All rights reserved. Purpose: Brain metastases have a highly variable prognosis depending on the primary tumor and associated prognostic factors.
Sarfaraz, Mehrdad +7 more
core +1 more source
Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma
Background Novel treatments make long‐term survival possible for subsets of patients with melanoma brain metastases. Brain magnetic resonance imaging (MRI) may aid in early detection of brain metastases and inform treatment decisions. This study aimed to
Annemarie C. Eggen +7 more
doaj +1 more source
Lung cancer is one of the most common causes of brain metastases and is always associated with poor prognosis. We investigated the immunophenotypes of primary lung tumors and paired brain metastases, as well as immunophenotypes in the synchronous group ...
Meichen Li +11 more
doaj +1 more source
Treatment of brain metastases [PDF]
Brain metastases are a very common neurological sequela in cancer patients. The ability of current anti-cancer therapies to prolong overall survival is beleaguered by this development in the case of a number of different cancers. This review provides a general overview of relevant treatment modalities, highlights major decision strategies used in ...
Marcel Matzenauer +2 more
openaire +3 more sources
Glecirasib treatment in KRAS G12C-positive non-small cell lung cancer with leptomeningeal metastasis
BackgroundLeptomeningeal metastasis (LM) is associated with poor outcomes in non-small cell lung cancer (NSCLC), and clinical evidence for KRAS G12C inhibition in this setting is limited.
Yunfei Li +9 more
doaj +1 more source
Background This study is in regard to the comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the
Xiaofang Zhang +6 more
doaj +1 more source
Radiotherapy for head and neck cancer must balance disease control against normal-tissue injury. Artificial intelligence (AI), multi-omics, and multimodal analysis offer complementary ways to characterize tumor and host heterogeneity, but their relevance
Miao Rao +3 more
doaj +1 more source
Brain metastases originating from different primary sites overlap in appearance and are difficult to differentiate with conventional MRI. Dynamic contrast‐enhanced (DCE)‐MRI can assess tumor microvasculature and has demonstrated utility in characterizing
Vaios Hatzoglou +7 more
doaj +1 more source
s: Background: Pancreatic ductal adenocarcinoma (PDAC) often presents with metastases. Brain metastases are rare, necessitating a thorough analysis of patient profiles and management.
Yuanchi Ma +6 more
doaj +1 more source

